Medytox Inc. 13D and 13G filings for Evolus, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-06 4:16 pm Sale |
2024-12-31 | 13G | Evolus, Inc. EOLS |
Medytox Inc. | 2,136,449 3.400% |
-1,244,877 (-36.82%) |
Filing |
| 2023-10-18 4:17 pm Sale |
2023-10-16 | 13G | Evolus, Inc. EOLS |
Medytox Inc. | 3,381,326 5.900% |
-3,915,217 (-53.66%) |
Filing |
| 2023-02-06 4:12 pm Sale |
2022-12-31 | 13G | Evolus, Inc. EOLS |
Medytox Inc. | 7,296,543 12.970% |
-167,109 (-2.24%) |
Filing |
| 2022-02-08 9:55 pm Purchase |
2021-12-31 | 13G | Evolus, Inc. EOLS |
Medytox Inc. | 7,463,652 13.430% |
701,000 (+10.37%) |
Filing |
| 2021-03-01 5:22 pm Purchase |
2021-02-18 | 13G | Evolus, Inc. EOLS |
Medytox Inc. | 6,762,652 16.700% |
6,762,652 (New Position) |
Filing |